Global rise of multidrug resistant tuberculosis threatens to derail decades of progress

Incurable TB: Patients die without dignity
24th March 2017
Tuberkulose: Nuwe medisyne bring hoop
25th March 2017

Global rise of multidrug resistant tuberculosis threatens to derail decades of progress

New antibiotics are becoming available for the first time but without accurate diagnostics, clear treatment guidelines, and improved control efforts, their effectiveness could be rapidly lost

The rise of multidrug-resistant (MDR) and extensively drug-resistant (XDR) tuberculosis (TB) threatens to derail decades of progress in controlling the disease, according to a new report in The Lancet Respiratory Medicine.

Although a small number of repurposed and new drugs have recently become available to treat drug-resistant TB (including bedaquiline, delamanid, and linezolid), the authors warn that without accurate diagnostic tests to deliver individually targeted treatments, clear prescription guidelines on appropriate use and improved control efforts to prevent transmission, optimal dosing and administration, and well-functioning health care systems, the effectiveness of the drugs could be rapidly lost.

Read more Medical News Today, 24 March 2017

Do NOT follow this link or you will be banned from the site!